Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T20:26:39.120Z.
Calculation as of: 2026-10-06T20:26:39.120Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8dac276dab9b72f767ef95dff0a018bdb1655164ea652fec6d95688d7a2c4747
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Vyome Holdings, Inc.
Market Cap
$14.46M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Vyome Holdings, Inc. (HIND) | $14.46M | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.05M | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | N/A |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | N/A |
| Jin Medical International Ltd. (ZJYL)vs › | $15.58M | N/A |
| IN8bio, Inc. (INAB)vs › | $13.33M | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.30M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
